Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2020-12-03
Product name
GAVRETO(TM) Capsules 100 mg
Product Synonyms
GAVRETO Capsules (hard) 100 mg
1.2.1 Relevant identified uses
Formulated pharmaceutical active substance
supplier name
Genentech, Inc
Emergency telephone
US Chemtrec phone
Icons in SDS
Company Information
company name
Genentech, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H361d, H373
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
OSHA Hazards GHS classification in accordance with the OSHA Hazard Communication Standard (29 CFR 1910.1200) Carcinogenicity Category 2 Reproductive toxicity Category 2 Specific target organ toxicity Category 2 (Cardiovascular, Skeleton, hematopoietic system) - repeated exposure
Signal word
Warning
Hazard statements
H351 Suspected of causing cancer. H361d Suspected of damaging the unborn child. H373 May cause damage to organs (Cardiovascular, Skeleton, hematopoietic system) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
None known.
